Potassium Iodide tablets

The Strategic Medical Countermeasures Program (SMCP), on behalf of the Canadian Forces Health Services Group (CF H Svcs Gp) has a requirement for Potassium Iodide tablets for use as a thyroid blocking agent for use in nuclear emergencies which involve the release of radioiodine. The Contract Period will be from contract award to 31 March 2030. The Crown retains the rights to negotiate with suppliers on any procurement. Documents may be submitted in either official language of Canada. Policy on Reciprocal Procurement: This solicitation of offers is open only to Canadian suppliers (if subject to any international trade agreement(s)): and to Suppliers of an applicable trading partner. Applicable trade agreements: Canadian Free Trade Agreement Canadian-Colombia Free Trade Agreement Canada-Honduras Free Trade Agreement Canada-Panama Free Trade Agreement Canada-Korea Free Trade Agreement Canada-Peru Free Trade Agreement Canada-Chili Free Trade Agreement